India leads the way—with Ivermectin

Why has this story—and the truth about that drug—been totally blacked out by the US “healthcare” establishment, and “our free press”?

There is no undisturbing answer to that question.

“When asked about the lack of clinical trial data on Ivermectin, Dr Surya Kant said that over 40 such trials are underway, and not one has reported any major side effects yet. “More than 40 clinical trials are underway, including eight in India. This includes the most prestigious institute in India i.e. AIIMS Delhi. The trial underway at AIIMS is also on five different types of doses of Ivermectin, which is a very important issue. So, all kinds of trials are underway. My whitepaper was published in the month of July 2020. In the whitepaper, 19 Indian experts have contributed. They collected and compiled all data available on Ivermectin since 1981, when the drug was introduced to the world. Both researchers (William C. Campbell of US and Satoshi Ōmura from Japan) who discovered this drug won the 2015 Nobel Prize in Physiology or Medicine for discovering this drug. It has got more than four properties – anti-viral, anti-parasitic, anti-cancer, and even anti-HIV. This is a wonderful drug, low cost, widely available and used for last 40 years throughout the world.”

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.